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Signal transductionSH3 domains are evolutionarily conserved protein interaction domains that control nearly all cellular processes
in eukaryotes. The current model is that most SH3 domains bind discreet PxxPxR motifs with weak afﬁnity and
relatively low selectivity. However, the interactions of full-length SH3 domain-containing proteins with ligands
are highly speciﬁc and have much stronger afﬁnity. This suggests that regions outside of PxxPxR motifs drive
these interactions. In this study, we observed that PxxPxR motifs were required for the binding of the adaptor
protein GRB2 to short peptides from its ligand SOS1. Surprisingly, PxxPxR motifs from the proline rich region
of SOS1 or CBL were neither necessary nor sufﬁcient for the in vitro or in vivo interaction with full-length
GRB2. Together, our ﬁndings show that regions outside of the consensus PxxPxR sites drive the high afﬁnity
association of GRB2 with SH3 domain ligands, suggesting that the binding mechanism for this and other SH3
domain interactions may be more complex than originally thought.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
SH3 domain-containing proteins regulate a large number of cellular
functions in humans from signal transduction to metabolism to differ-
entiation [1,2]. SH3 domains are evolutionally conserved in eukaryotes
from budding yeast, which produce 28 proteins with SH3 domains, to
humans, which express over 300 proteins with SH3 domains [1,3]. Al-
though sequence conservation is relatively low, SH3 domains have a
conserved structure of 5 or 6 beta strands that form two anti-parallel
beta sheets. The current model is that vast majority of SH3 domains
bind to discrete sequences of (R/K)xPxxP (class I) or PxxPx(R/K)
(class II) in a shallow groove between the beta sheets [2,3]. Peptide
ligands containing these motifs associate in vitro with isolated SH3 do-
mains with relatively weak afﬁnities, ranging from 1 μM to 1 mM [2,4].
There are other atypical interaction motifs that associate with a small
number of SH3domains. Themostwell studied of these is these atypical
interactions are class III binding reactions driven by RxxKmotifs. In con-
trast to class I or class II SH3 domain binding reactions, the afﬁnity of
class III SH3 domain interaction appears to be much stronger [1,3,5].ermal titration calorimetry; PRR,
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pply, 2000 Rockford Rd, CharlesIn addition to relatively low afﬁnities, isolated SH3 domains also have
variable speciﬁcity for peptide ligands. Some isolated domains have
relatively high speciﬁcity for individual ligands, notably the class III
C-terminal SH3 domain of GADS and RxxK peptides from SLP-76, but
the majority of class I and class II SH3 domains bind multiple PxxP
containing peptides [2,4]. Based primarily on studies using isolated
domains and peptide ligands, the current model is that SH3 domains
are evolutionally and structurally conserved protein interaction domains
that have weak afﬁnity and low speciﬁcity for PxxP containing ligands.
In contrast to isolated SH3 domain/peptide interactions, the binding
of full-length SH3 domain containing proteins to larger regions of their
ligandshas substantially stronger afﬁnity. The binding afﬁnity of the iso-
lated C-terminal SH3 domain of GADS to a peptide derived from SLP-76
was ~250 nM, while the interaction of full-length GADS with the com-
plete proline-rich region of SLP-76 is ~10-fold stronger [5,6]. Similarly,
the SH3 domain of p67PHOX binds with 1000-fold increased afﬁnity
to a 32 amino acid peptide derived from p47PHOX compared to shorter
peptides due to molecular interactions outside of the PxxP motif [7,8].
Finally, peptides derived from PxxP motifs found in SOS1interact with
individual SH3 domains from GRB2 with afﬁnities ranging from 20 μM
to 1 mM [9–13], whereas the association of full-length GRB2 with
full-length SOS1 or the complete proline rich regions (PRR) of SOS1 and
CBL has afﬁnities of 300–400 nM [14–16]. Together, these studies suggest
that the interaction of full-length SH3 domain-containing proteins with
in vivo ligands may have substantially stronger afﬁnity than previously
thought due to interactions outside of the conserved PxxP motifs.
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physical and imaging techniques to examine the binding of GRB2 to
its physiological ligands SOS1 and CBL. GRB2 is an adaptor protein
with a central SH2 domain, which binds to phosphorylated proteins,
and two ﬂanking SH3 domains [17,18]. GRB2 facilitates the interaction
of phosphorylated receptors and adaptor proteins with SH3 domain
ligands, including the RAS guanine nucleotide exchange factor SOS1
and the E3 ubiquitin ligase, CBL [17,18]. In this study,we found that sim-
ilar to previous observations PxxPxR motifs were absolutely required
for the interaction of full-length GRB2 with peptides derived from the
proline rich C-terminal tail of SOS1. In contrast, these same PxxPxRmo-
tifswere neither necessary nor sufﬁcient for the high afﬁnity interaction
of SOS1 or CBL with full-length GRB2 or required for the in vivo recruit-
ment of SOS1 to theplasmamembrane in activated T cells. These studies
show conclusively that regions outside of the PxxPxR motifs are critical
for the high afﬁnity interaction of GRB2 with full-length ligands.
2. Material and methods
2.1. Protein puriﬁcation
The bacterial expression constructs for full-length human GRB2, the
complete proline rich region of murine SOS1 or human CBL were
described previously in [6,15]. Deletions of individual sites in these
constructs were performed with the QuickChange II XL Site Directed
Mutagenesis kit from Stratagene using standardmanufacturer protocol.
Rosetta 2 cells expressing 6X-His tagged GRB2 were shaken for 36 h at
25 °C in Superbroth. Rosetta 2 cells expressing 6X-His tagged proline
rich regions of SOS1 or CBL were shaken 24–48 h at 37 °C in ZYM-
5052 [19]. The cells were pelleted, and pellets were then resuspended
in His-tag puriﬁcation buffer (50 mM NaPO4, 250 mM NaCl, pH 7.4) and
lysed using sonication. The supernatant was applied to a Ni2+ HisTrap
HP afﬁnity column and bound proteins were eluted using imidazole.
Proteins were further puriﬁed by size exclusion chromatography using a
16/60 Superdex 75 gel ﬁltration column and then concentrated using
10,000MWCO centrifugal ﬁlters. As determined by dynamic light scatter-
ing, little aggregation was observed for any protein (data not shown).
2.2. Peptide array
The peptide array was produced as previously described in [20]. The
array scans the entire proline rich region of SOS1 (amino acids 1117–
1319) and contains 12 amino acid peptides that have 9 amino acid
overlaps with the peptides on either side (see key for the array in
Supplemental Fig. 1). The membrane was blocked with 5% milk in
TBST and then incubated with His-tagged GRB2 for 1.5 h. The amount
of bound GRB2 was examined by immunoblotting with an anti-GRB2
antibody diluted in 5% milk as previously described in [21] and the
array was visualized by chemiluminescence using a Fuji imager.
2.3. Isothermal titration calorimetry (ITC)
The protein sampleswere degassed and ITCmeasurements recorded
using aMicroCal VP-ITC Systemwith SOS1 or CBL proline rich regions as
the injected sample and GRB2 as the cell sample. For the peptide inhibi-
tion studies, GRB2 was incubated with varying molar ratios of a SOS1
site 1 peptide (EVPVPPPVPPRRRPE) purchased from EZ Biolabs. The
chamber was kept under constant stirring at 350 rpm and all experi-
ments were performed at 25 °C. Injection of SOS1 or CBL into buffer
showed constant heats of dilution. The heat of dilution was determined
by averaging the last 3–5 injections and subtracted from the raw value.
The data are analyzed using the single site binding model using the Or-
igin ITC analysis package. The values for afﬁnity, stoichiometry and ΔH
were averaged from at least four separate injections and statistically an-
alyzed via ANOVA using GraphPad Prism. Outliers in the data were de-
termined via the ROUT method using GraphPad Prism, with Q = 0.1 %.2.4. Dynamic light scattering
Dynamic light scattering (DLS) data was collected at 25 °C using a
DynaPro NanoStar (Wyatt Technology). The data was analyzed using
Dynamic (version 7.1.7,Wyatt Technology). Each acquisitionwas an av-
erage of 10 scans and the values for radius and percent polydispersity
were averaged from four individual acquisitions. The data was plotted
and statistically analyzed via ANOVAwith Tukey's multiple comparison
test using GraphPad Prism.
2.5. Cell lines and transfections
SOS1 wild-type, SOS1 Δ1234Z, and SOS1 scrambled cDNA were PCR
ampliﬁed from plasmid constructs and inserted into lentiviral expres-
sion vectors (Gift from Dr. Stephen Bunnell). The lentiviral expression
vectors and packaging vectors were cotransfected into 293T cells
using lipofectamine 2000. After 48 h, the virus-containing medium
was removed and virus was concentrated using Lenti-X concentrator
(Clontech). Jurkat E6.1 T cells were grown at 37 °C with 5% CO2 in com-
plete RPMI (RPMI 1640 supplementedwith 10% FBS, 2mM L-glutamine,
50 U/mLpenicillin, 50 μg/mL streptomycin). Theywere transducedwith
the described vectors and selected using puromycin. YFP expression on
stable cell lineswas analyzed byﬂow cytometry using anAccuri C6 ﬂow
cytometer.
2.6. Immunoblotting
Proteins in cellular lysates were separated by polyacrylamide gel
electrophoresis using 4–15% Criterion Precast polyacrylamide gels. The
separated proteins were then transferred to polyvinylidene diﬂuoride
and the membrane was blocked for 1 h at room temperature in SEA
BLOCK Blocking Buffer. The membranes were incubated overnight at
4 °C with anti-YFP followed by 30 min of incubation at room tempera-
ture with the respective secondary antibody. The blots were then
developed using the Licor Odyssey Infrared Imager.
2.7. TIRF microscopy
Imagingwas performed using a Leica AMTIRFMC imaging system as
previously described [22,23]. Brieﬂy, Jurkat E6.1 T cells stably express-
ing SOS1 wild-type PRR–YFP, SOS1 Δ1234Z PRR–YFP, or YFP alone
were activated for 5 min on glass chamber slides coated with 10 μg/ml
of anti-CD3 antibody. Cells were ﬁxed with 3% paraformaldehyde and
permeabilized with 0.25% Triton X-100. After blocking, cells were
stained with anti-phospho LAT Y226 antibodies followed by incubation
with secondary antibodies. The YFP ﬂuorescence and LAT phosphoryla-
tion occurring at the membrane was imaged using TIRF microscopy.
The total YFP ﬂuorescence in the same cells was imaged by EPI ﬂuores-
cence. All images were acquired using Leica AF software and processed
using Fiji software package. To quantify YFP recruitment, the TIRF YFP
ﬂuorescence was normalized to the total YFP ﬂuorescence in the EPI
ﬂuorescence channel in the imaged cell. The ratio of the values of TIRF
YFP ﬂuorescence over total YFP ﬂuorescence in the EPI ﬂuorescence
channel was calculated for 40 randomly selected cells for each of the
two independent experiments. The individual values and the mean ±
95% conﬁdence intervals were plotted using GraphPad Prism. The statis-
tical analysis was performed using GraphPad Prism via ANOVA analysis.
3. Results
3.1. PxxPxR motifs are required for the binding of GRB2 to peptide ligands
The proline rich C-terminal tail of SOS1 PRR contains four consensus
PxxPxR SH3 domain binding motifs, and peptides containing these
motifs bind individual GRB2 SH3 domains with afﬁnities ranging from
20 μM to 1 mM [9–13]. Although these studies have shown that GRB2
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been performed to determine if these consensus motifs are necessary
for full-length GRB2 binding or to identify novel binding sites. To ad-
dress these questions, we produced a synthetic peptide array with 12
amino acid long peptides derived from the PRR of SOS1 that have nine
amino acid overlaps with adjacent peptides (Supplemental Fig. 1).
Full-length GRB2 bound to peptides that contained PxxPxR motifs
from site 1 (Fig. 1A, A7) and site 4 (Fig. 1A, C5).We also identiﬁed a pre-
viously unknown atypical proline rich region with the sequence of
FFPNSPSPFTPP christened site Z (Fig. 1A, B16). GRB2 did not interact
with 12 amino acid peptides containing site 2 (Fig. 1A, A15–A17) or
site 3 (Fig. 1A, B2–B4). However, a 15 amino acid site 2 peptide bound
well to GRB2 (Fig. 1A, C20 and D4), while a 15 amino acid site 3 peptide
had only minimal binding (Fig. 1A, C21). Mutations of the PxxPxRmotif
to AxxAxK abolished binding to sites 1–4 (Fig. 1A, C23–D2). Important-
ly, GRB2 did not associate with the class 1 SH3 domain binding sitewith
the consensus sequence of RxxPxxP (Fig. 1A, B22 and B23). Similarly,
GRB2 did not associate with other proline rich peptides including
PESAPAESSP (Fig. 1A, A10), DPPES (Fig. 1A, A24 and B1), PLHLQPPPL
(Fig. 1A, B9, B10), PPPPQTPSP (Fig. 1A, B18 and B19), PSPPL (Fig. 1A,
B22 and B23), PKLPPKT (Fig. 1A, C9 and C10), and PSMHRDGPP (Fig. 1A,
C14 and C15).
The 15 amino acid site 2 peptide that boundwell with GRB2 contains
an HLxSPP motif found in the N-terminal and C-terminal halves of the
complete PRR of SOS1. The two halves of the PRR of SOS1 have previous-
ly been shown to bind with GRB2 in a 1:1 stoichiometry[15]. Since the
HLxSPP motifs are the only conserved sequences outside of the PxxPxR
motifs on both halves of the PRR of SOS1, the role of the HLxSPP regionFig. 1. PxxPxRmotifs are required for binding of full-length GRB2 to SOS1 peptides. Full-length h
of GRB2 to the array was assessed by immunoblotting with an anti-GRB2 antibody. Peptides coon the binding to the site 2 peptide was examined. Serine phosphoryla-
tion or individual alaninemutations of the HLxSPPmotif did not disrupt
binding of the site 2 peptide toGRB2 (Fig. 1A, D6–D11),whereas alanine
mutation of all sites on this region reduced GRB2 binding (Fig. 1A, D12).
These data show that in the context of short, 12–15 amino acid long
peptides, the PxxPxR motifs found in sites 1, 2 and 4 and a novel inter-
action region, site Z, bind to full-length GRB2. Importantly, no other
short 10–12 amino acid GRB2 binding sites outside of PxxPxR motifs
were observed in the complete PRR of SOS1.
3.2. PxxPxR-containing peptides do not inhibit the interaction of GRB2with
the complete SOS1 PRR
SOS1 site 1 peptides inhibit the interaction of GRB2 with SH3 do-
main ligands in cellular lysates [9,24,25]. This provided direct evidence
that the GRB2:SOS1 is driven by the PxxPxR motifs, but the molar
ratio of the peptides to endogenous proteins was unknown calling
into question these conclusions. To address this issue, full-length GRB2
was mixed with varying molar ratios of a SOS1 site 1 peptide (EVPVPP
PVPPRRRPE) and the subsequent binding of wild-type complete PRR
of SOS1 was analyzed by isothermal titration calorimetry. This tech-
nique is widely utilized for measuring the afﬁnity, stoichiometry and
thermodynamics of a protein–protein interaction [26,27]. Addition of
two or ﬁve molar equivalents of the SOS1 peptide had no signiﬁcant
effect on the afﬁnity, change in enthalpy (ΔH) or stoichiometry of the
interaction of GRB2 with the complete PRR of SOS1 (Fig. 2). The lack
of suppression is especially striking in the ﬁrst injections, where the
SOS1 peptide is at a 33x and 83x molar excess compared to theumanGRB2was incubatedwith a peptide array derived from the PRR of SOS1. The binding
ntaining PxxPxR motifs are described below the blot.
Fig. 2. SOS1 peptidewith a PxxPxRmotif does not signiﬁcantly inhibit the interaction of GRB2with the complete proline rich region of SOS1. A) Full-length GRB2was pre-incubatedwith a
SOS1 site 1 peptide. The ability of the peptide to inhibit the binding of GRB2 to the complete proline rich region of SOS1was then assessed via ITC. Each point on the curve is an average±
95% conﬁdence interval of 2 or 3 replicates. The curves were ﬁt using the Boltzmann sigmoidal equation in GraphPad Prism. B) The values for afﬁnity, change in enthalpy (ΔH) and stoi-
chiometry from three independent experiments are shown. The statistical analysis was performed using GraphPad Prism via ANOVA analysis and p values for the comparison of the no
peptide control to 2:1 or 5:1 molar ratio of peptide are shown.
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equivalents, respectively. Thuswhen themolar ratios are similar, a SOS1
peptide containing PxxPxR motif is incapable of signiﬁcantly inhibiting
the GRB2:SOS1 interaction. Unlike previous studies, this suggests
that the PxxPxR motifs are not a major component of the high afﬁnity
interaction of the full-length proteins.
3.3. Regions outside of the PxxPxR motifs drive high afﬁnity in vitro
interactions of GRB2 with SH3 domain ligands
To further address this paradigm shifting possibility, the ability of
PxxPxR motifs to drive the high-afﬁnity interaction of GRB2 with the
PRR of SOS1 was assessed. The complete PRR of SOS1 and mutants
with individual or combined deletions of sites 1–4 and site Z (Fig. 3A)
were isolated and the afﬁnity, ΔH or stoichiometry of these proteins
for GRB2was determined by ITC. The association of GRB2with the com-
plete PRRof SOS1 is enthalpically drivenwith an afﬁnity of ~360nMand
a 2 GRB2:1 SOS1 stoichiometry [15]. Surprisingly, there were no statis-
tically signiﬁcant differences in the afﬁnity for the interaction of GRB2
with SOS1 proteinswith sites 2, 3, Z or 4 deleted alone or together com-
pared to WT SOS1 or ΔH and stoichiometry for the binding of GRB2 to
SOS1 proteins with sites 1, 2, 3, Z or 4 deleted alone or together com-
pared to WT SOS1 (Table 1 and Fig. 3B). There was a statistically signif-
icant difference in the afﬁnity for the interaction of GRB2 with SOS1
Δsite1 (Table 1 and Fig. 3B). However, the difference in afﬁnity was
only 1.7 fold, which unlikely to physiologically relevant. Additionally,
deletion of the two HLxSPP motifs conserved in the N-terminal and
C-terminal sides of the complete proline rich region of SOS1 (N-terminal:
ΔSite A and C terminal: ΔSite B; Fig. 2A) had no signiﬁcant effect on the
GRB2 binding reaction (Table 1 and Fig. 3B). To test if the PxxPxR sites are
sufﬁcient for the binding of GRB2 to SOS1, a mutant SOS1 PRR was
produced where sites 1, 2, 3, Z and 4 were conserved in sequence and
position but all other amino acids were randomly repositioned
(scrambled; Fig. 3A). The scrambled version of the SOS1 PRR hadno detectable bindingwith GRB2 (Table 1 and Fig. 4A). Based on the con-
centrations used for these studies, it is estimated that the afﬁnity of SOS1
scrambled for GRB2 is greater than 50 μM. These experiments suggest
that the PxxPxR motifs or sequences needed for interactions with these
motifs in the context of short peptides are not required for the high-
afﬁnity binding of GRB2 to SOS1.
Since these observationsdirectly challenges the currentmodel of SH3
domain binding reactions, we further examined the requirement of
PxxPxR motifs for high afﬁnity GRB2:SOS1 binding using dynamic light
scattering,which determines the hydrodynamic radius of a protein com-
plex. GRB2 had a radius of 4.0 nM, whereas SOS1 WT, Δ1234Z and
scrambled had radii of 5.0, 4.6, 3.5 nM, respectively (Fig. 4B). Interesting-
ly, the 2:1 stoichiometric mixture of GRB2with either SOS1wild-type or
SOS1 Δ1234Z had a signiﬁcantly larger radii of 6.9 and 5.6 nM, respec-
tively, than the unbound GRB2 or SOS1 proteins (Fig. 4B), indicating
that SOS1 proteinswith andwithout PxxPxRmotifs form larger 2:1 com-
plexes with GRB2. The smaller radius of the SOS1 Δ1234Z compared to
SOS1 wild-type is likely due to the molecular weight difference, but
could also be due to changes in the overall structure of the complex. In
contrast, the 2:1 mixture of GRB2 with SOS1 scrambled had a radius of
3.7 nM (Fig. 4B), which is the average of the radii for unbound proteins.
Unlike SOS1wild-type and SOS1Δ1234Z, SOS1 scrambled is incapable of
interacting with GRB2. These results conﬁrmed our ﬁnding that high af-
ﬁnity binding between SOS1 and GRB2 is independent of PxxPxRmotifs.
It is possible that the inability of the PxxPxRmotifs to drive the high-
afﬁnity binding reaction is limited to the GRB2:SOS1 interaction. To
examine this prospect, the binding of GRB2 to wild-type and mutated
versions of the complete PRR of CBL, which contains three identiﬁed
PxxPxR GRB2 binding motifs (Fig. 5A) [28], was characterized by ITC.
Again, deletion of the PxxPxRmotifs did not signiﬁcantly alter the afﬁn-
ity or stoichiometry for the binding of GRB2 compared to the wild-type
CBL PRR (Table 1 and Fig. 5B). There was a signiﬁcant difference in the
ΔH value for these reactions, but a ~40% change is unlikely to have
any meaningful physiological effect.
Fig. 3. The consensus PxxPxRmotifs of SOS1 are not required for thehigh afﬁnity interactionwithGRB2. A) The sequence for SOS1wild-type, SOS1Δ1234Z, SOS1ΔSite AB and SOS1 scram-
bled are shown. B) The binding of GRB2 to the complete proline rich regions of SOS1 was assessed by ITC. The values for afﬁnity,ΔH and stoichiometry were determined using the Origin
ITC analysis package. The individual values for afﬁnity,ΔH and stoichiometry were plotted with the average ± 95% conﬁdence interval using GraphPad Prism. The statistical analysis was
performed using GraphPad Prism via ANOVA analysis and the p values b 0.50 are shown.
Table 1
Afﬁnity, stoichiometry and change in enthalpy (ΔH) values for the interaction of GRB2
with WT and mutant complete proline rich regions from SOS1 and CBL. Each point is
shown as a mean ± SEM for at least four separate injections.
Afﬁnity
(nM)
Stoichiometry
(SOS1/GRB2)
Enthalpy
(kcal/mol)
SOS1 deletions
SOS1 WT 360 ± 40 0.55 ± 0.03 −32 ± 6
ΔSite 1 600 ± 50 0.53 ± 0.05 −32 ± 3
ΔSite 2 390 ± 30 0.45 ± 0.07 −40 ± 8
ΔSite 3 490 ± 60 0.63 ± 0.06 −29 ± 4
ΔSite 4 310 ± 60 0.53 ± 0.08 −30 ± 4
ΔSite Z 330 ± 50 0.54 ± 0.13 −28 ± 4
ΔSites 1,2,3,4,Z 360 ± 50 0.54 ± 0.04 −41 ± 1
ΔSite A 400 ± 90 0.51 ± 0.06 −26 ± 2
ΔSite B 380 ± 110 0.44 ± 0.08 −34 ± 10
Scrambled N50,000 N.D. N.D.
CBL deletions
CBL WT 520 ± 120 0.45 ± 0.04 −16 ± 1
ΔSites 1,2,3 800 ± 70 0.34 ± 0.03 −10 ± 2
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SOS1
Upon T cell receptor (TCR) activation, GRB2 recruits SOS1 to the
membrane adaptor protein LAT. Both GRB2 and SOS1 are then critical
for the clustering of LAT into large megadalton sized signaling
complexes [15,29,30]. To translate the biophysical studies to a cellular
context, stable Jurkat E6.1 T cell lines were produced that had similar
levels of YFP alone (YFP), wild-type complete proline rich region
SOS1-YFP (WT-YFP) and Δ1234Z proline rich region SOS1-YFP
(Δ1234Z-YFP) expression as assessed by ﬂow cytometry and immuno-
blotting (Fig. 6A and B). Unfortunately, SOS1 scrambled-YFP could not
be transiently or stably expressed (Fig. 6A and B). Recombinant SOS1
scrambled aggregated more quickly than other SOS1 proteins and had
higher polydispersity in DLS experiments compared to WT SOS1 (data
not shown). Together this suggests that SOS1 scrambled is unstable in
human cells. T cell activation by anti-TCR-coated coverslips results in
LAT phosphorylation and the recruitment of GRB2 and SOS1 to the
Fig. 4.Regions outside of the consensus PxxPxRmotifs are required for the high afﬁnity interaction of GRB2with SOS1. A) Raw ITC tracings for the interaction of GRB2with SOS1WT, SOS1
Δ1234Z and SOS1 scrambled. Each trace is representative of at least 4 separate injections. B) The hydrodynamic radius of GRB2, SOS1WT, SOS1Δ1234Z or SOS1 scrambled, both alone and
in combination, was determined using DLS. The individual values, with themean± 95% conﬁdence intervals were plotted using GraphPad Prism. Statistical analysis was performed using
GraphPad Prism via ANOVA analysis and the p values are shown.
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LAT was assessed by total internal reﬂection (TIRF) microscopy, which
lowers background ﬂuorescence by exciting molecules within 150 nM
of the coverslip [32]. TCR stimulation induced substantial phosphoryla-
tion of LAT and the recruitment of WT SOS1-YFP and Δ1234Z SOS1-YFP
to the plasma membrane (Fig. 6C) in Jurkat T cells expressing SOS1-YFP
fusion proteins. In contrast, activated Jurkat T cells expressing YFP alone
had increased LAT phosphorylation but no YFP recruitment to the mem-
brane (Fig. 6C). To quantify YFP recruitment, the TIRF YFP ﬂuorescence
was normalized to the total YFP ﬂuorescence in the EPI ﬂuorescence
channel in the imaged cell. There was no signiﬁcant difference in the re-
cruitment of WT SOS1-YFP and Δ1234Z SOS1-YFP to the membrane,
while YFP had signiﬁcantly lower recruitment compared to the SOS1 pro-
teins (Fig. 6D). These data conclusively show that the complete PRR of
SOS1 missing all PxxPxR motifs is recruited to membrane signaling com-
plexes in activated T cells to a similar level as wild-type SOS1 PRR.
4. Discussion
Similar to previous studies [9–13], our data show that PxxPxRmotifs
can facilitate the SH3 domain-mediated binding of GRB2 to SOS1
peptides. Importantly, these sites were the only discreet 10–12 amino
acid sequences that can mediate the interaction of GRB2 with SOS1.
In contrast to the peptide studies, the same PxxPxR motifs are neithernecessary nor sufﬁcient for the high afﬁnity in vitro binding of GRB2 to
the complete PRR of SOS1 or CBL. Similarly, these sites are not required
for the recruitment of SOS1 PRR to activated LAT, an excellent model for
the receptor stimulation-dependent recruitment of the GRB2/SOS1
complex [17]. Instead, as shown by our studieswith the SOS1 scrambled
mutant, regions outside of the consensus PxxPxRmotifs drive the inter-
action of the complete proline rich region of SOS1 and CBL with full-
length GRB2. These ﬁndings are in contrast to work by McDonald and
coworkers, who showed that PxxPxRmotifs were critical for the binding
of GRB2 to the PRR or SOS1.However, these investigators used a truncat-
ed PRR for SOS1 that had an afﬁnity of only 7 μMfor GRB2 [33]. The SOS1
PRR used in this study bound to GRB2 with an afﬁnity of 350 nM, which
is nearly identical to the afﬁnity of GRB2 for full length SOS1 [14]. Ulti-
mately, our studies show that in the context the full length proline
rich regions of SOS1 and CBL, the PxxPxR motifs are not required for
the high afﬁnity in vivo and in vitro interaction with GRB2.
These observations ﬁt well with previous studies showing that SOS1
peptides bind to individual SH3 domains from GRB2 with afﬁnities
ranging from 20 μM to 1 mM [9–13], while the afﬁnity for the binding
of full-length GRB2 with full-length SOS1 or the complete PRR of SOS1
and CBL is between 300 and 400 nM (Table 1) and [14–16]. Several
studies have suggested that the differences in the afﬁnity GRB2 for
peptides versus full length ligands were due to avidity effects, where
both SH3 domains of an individual GRB2 bind to two PxxPxR motifs
Fig. 5. The consensus PxxPxRmotifs of CBL are not required for thehigh afﬁnity interactionwith GRB2. A) The sequence for CBLwild-type andCBLΔ123 is shown. B) The bindingof GRB2 to
the complete proline rich regions of CBLwas assessed by ITC. The values for afﬁnity,ΔH and stoichiometrywere determined using theOrigin ITC analysis package. The individual values for
afﬁnity, ΔH and stoichiometry were plotted with the average ± 95% conﬁdence interval using GraphPad Prism. The statistical analysis was performed using GraphPad Prism via ANOVA
analysis and the p values b 0.50 are shown.
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tions can strengthen the afﬁnity of the GRB2/SOS1 interaction [34]
and peptides with two linked PxxPxR motifs had enhanced binding
of GRB2 compared to peptides with a single motif [35,36]. However,
our data conclusively show that avidity effects derived from the in-
teraction of a single GRB2withmultiple PxxPxRmotifs on an SH3 do-
main ligand cannot explain the 2–3 orders of magnitude differences
in afﬁnity for peptides versus full-length ligands.
If PxxPxR motifs on SOS1 and CBL are not high afﬁnity binding sites
for GRB2,what is themolecularmechanism for this binding reaction?As
shown in Fig. 1, there are no discrete binding sites outside of PxxPxR
motifs that bind GRB2. Since the interaction of these peptides with
GRB2 SH3 domains have mid to high μM afﬁnities, this suggests that
no other short sequences on SOS1 have afﬁnities for GRB2 SH3 domains
stronger than 100 μM. Thus, the current paradigm that GRB2:SH3
domain interactions are controlled by short discreet binding sites is
incorrect (Fig. 7). Instead, these binding reactions are likely driven by
large number of low afﬁnity contacts across the entire PRR of individual
ligands. What the actual contacts are that drive the interaction of GRB2
with either SOS1 or CBL are outside of the scope of this study. The crystal
structure of full length GRB2 has been solved, but cysteinemutations on
GRB2were required for crystallization [37,38]. Additionally, small angle
X-ray scattering studies have suggested that this structure does not
match conformation of the solution conformation of GRB2 [36]. We
have not been able to successfully produce diffractable crystals using
non-mutated full-length GRB2, due largely to the ﬂexible conformation
of this protein (data not shown). Similarly, the only assigned HSQC
spectra for full-length GRB2 was performed using a cysteine mutated
GRB2 [36]. It is unlikely that the interaction of non-mutated, full length
GRB2 with the PRR of SOS1 or CBL will be easily investigated by NMR
due to the large size of the complex and difﬁculty with the structurally
ﬂexible GRB2. Extensive studies usingmultiple genetic, biochemical and
biophysical techniques will be required to conclusively identify the
exact residues regulating the high afﬁnity interaction of GRB2 with
SH3 domain ligands.
If the PxxPxR motifs do not drive the high afﬁnity interaction of
GRB2 with SH3 domain ligands, what is their cellular function? ThePxxPxR motifs are conserved in SH3 domain ligands and are capable
of low afﬁnity interactions with SH3 domains. This strongly suggests
that these sites have some capacity to regulate the binding and/or
function of SH3 domain-mediated interactions. One possibility is
that PxxPxR motifs could facilitate structural stability in the SH3
domain-containing proteins. In support of this idea, recent studies
have shown that the linker regions surrounding SH3 and other inter-
action domains in Abl and PLC-γ1 regulate the dynamics of the inter-
action cassettes [39–41]. The PxxPxR motifs could be critical for the
stable binding with SH3 domains. Deletion of the PxxPxR motifs
may shift the on and off rates of the interaction in a linked manner
such that equilibrium afﬁnity does not change compared to the
wild-type protein. An additional possibility is that the PxxPxR motifs
are low afﬁnity interaction regions that serve as promiscuous bind-
ing sites for a large number of SH3 domains. Upon binding, other
binding contacts that are present only ligands with high speciﬁcity
then drive the high afﬁnity interaction. Essentially, this model
would suggest that the PxxPxR motifs serve as “landing lights” that
guide SH3 domain–ligand interactions, but then do not play a
substantial role in the ﬁnal binding mechanism. ITC and DLS are
equilibrium systems that cannot identify changes in the kinetics or
multistep mechanism of protein–protein interactions; thus, these
subtle changes would not be identiﬁed by these methods. An addi-
tional possibility is that the PxxPxR motifs could be critical for the
formation of the correct structure needed for connecting to down-
stream signaling. The PxxPxR motifs may be vital for correctly orien-
tating different regions of SH3 domain ligands to facilitate further
protein–protein interactions needed for enzymatic function. The
substantial difference in the hydrodynamic radius of the GRB2–
SOS1WT compared to the GRB2–SOS1Δ1,2,3,4,Z mutant would sup-
port such a model. Together, our studies show that the main function
of the PxxPxR motifs in the proline rich regions of SOS1 and CBL are
not to drive the high afﬁnity interaction with GRB2, but instead are
likely to have more subtle effects that regulate cellular function of
these proteins. The separate question from the focus of this manu-
script, speciﬁcally how PxxPxR motifs alter the cellular function of
SH3 domain ligands, will be the goal of future studies.
Fig. 6. SOS1 wild-type and SOS1 Δ1234Z are recruited to the plasma membrane upon TCR activation in human T cells. The expression of YFP fusion proteins in Jurkat E6.1 T cells stably
expressing SOS1 wild-type PRR–YFP (WT-YFP), SOS1 Δ1234Z PRR–YFP (Δ1234Z-YFP), SOS1 scrambled PRR–YFP (Scram-YFP) or YFP alone (YFP) was assessed by A) ﬂow cytometry or
B) immunoblotting. C) Jurkat E6.1 T cells stably expressing SOS1 wild-type PRR–YFP (WT-YFP), SOS1 Δ1234Z PRR–YFP (Δ1234Z-YFP) or YFP alone (YFP) were activated using coverslips
coated with a stimulatory anti-TCR antibody. The YFP ﬂuorescence and LAT phosphorylation occurring at the membrane was imaged using TIRF microscopy. LAT phosphorylation was
assessed by immunoﬂuorescence using a phospho-speciﬁc LAT Y226 antibody. The total YFP ﬂuorescence in the cell was imaged by EPI ﬂuorescence. D) The ﬂuorescence in the TIRF
and EPI ﬂuorescence channel was quantiﬁed for individual cells using NIH Image. The individual values and the mean ± 95% conﬁdence intervals were plotted using GraphPad Prism.
The statistical analysis was performed using GraphPad Prism via ANOVA analysis and the p value for each comparison is shown.
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The canonical model is that SH3 domains associate with ligands via
low speciﬁcity and afﬁnity interactions driven by PxxPxR motifs and
that selectivity for ligands is driven by an unknown mechanism
(Fig. 7). Our studies question the validity of this model. GRB2 may be
unique in requirement for PxxPxR motifs, but this is highly unlikely.
Thirty-ﬁve signaling proteins in humans contain adjacent SH2 and
SH3 domains [42]. At a minimum, the SH3 domain binding mechanism
in these proteins is likely conserved, but it is possible that the
mechanism for all SH3 domains is similar to GRB2. SH3 domains are
generally thought to be poor drug targets since the PxxPxR motifs are
relatively low afﬁnity and speciﬁcity [43,44]. If SH3 domain binding is
driven by interactions that are unique for each ligand, then this model
needs to be modiﬁed. However, the drug targeting screens must be
performed using large regions of the SH3 domain-containing protein
and its ligand. Additionally, SH3 domain-driven reactions will need to
be investigated in the context of full-length proteins and ligands, since
the use of peptide ligands and isolated SH3 domains may not fully
model the binding of the full length proteins. Our data suggest thatPxxPxR motifs are not required for the high afﬁnity binding of GRB2
with SH3 domain ligands, suggesting that the binding mechanism of
SH3 domain-containing proteins may be more complex than originally
thought.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.06.002.
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Fig. 7. Comparison of the current and revisedmodel for the interaction of GRB2with SH3 domain ligands. The current model suggests that PxxPxRmotifs are critical for the interaction of
GRB2 with SH3 domain ligands. These interactions are low afﬁnity and have variable ligand speciﬁcity driven by an unknown mechanism, making the poor clinical targets. Our revised
model indicates that the interaction of GRB2 with SH3 domain ligands is driven by multiple contacts outside of the PxxPxR motifs. These interactions are high afﬁnity and have ligand
speciﬁcity based on sequence differences; thus, these interactions could potentially be targeted for clinical intervention.
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